The following activities will continue to concentrate on the application of basic information concerning the inflammatory process to the study of diseases particularly arthritis and related conditions. These include: (1) detection of immune complexes in patients, determination of their mechanism of interaction with cells with and without complement participation, and analysis of the clinical relevance of such complexes; (2) determination of the role of immunogenetic factors in patients, especially those with inherited immunoglobulin and complement deficiencies, with analysis of and B & T lymphocyte antigens, HLA (& related markers) and other sixth chromosomal markers; (3) further analysis of the acquired abnormalities of the alternative complement pathway in paired synovial fluids and serum and how this system interacts with other humoral and cellular mediators of inflammation; (4) determination of the role of the plasma and urinary kinin-generating and fibrinolytic systems in synovial fluids, plasma and urine of patients with rheumatic diseases, vasculitis and related disorders; (5) analysis of the presence of mast cell derived mediators within the synovial fluid of patients with arthritis; (6) evaluation of the presence and mode of interaction of factors exerting chemotactic, chemokinetic, and inhibitory effects on neutrophils within the synovial fluid; (7) further characterization of the chemical mediators and related cellular events in cutaneous diseases with acquired immunologic abnormalities (immunodermatology); (8) determination of the role of humoral and cellular immunity collagen in patients with various forms of arthritis; (9) further characterization of mediators either released from lymphocytes or affecting lymphocytes; and (10) performance of studies on the effect of radiation in ameliorating rheumatoid synovitis.

Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Brigham and Women's Hospital
United States
Zip Code
Kay, J; Czop, J K (1994) Enhancement of human monocyte beta-glucan receptors by glucocorticoids. Immunology 81:96-102
Gladman, D D; Goldsmith, C H; Urowitz, M B et al. (1994) Sensitivity to change of 3 Systemic Lupus Erythematosus Disease Activity Indices: international validation. J Rheumatol 21:1468-71
McNeil, H P; Austen, K F (1994) Cytokine regulation of mouse mast-cell-specific protease genes. Adv Prostaglandin Thromboxane Leukot Res 22:71-81
Sperling, R I; Benincaso, A I; Knoell, C T et al. (1993) Dietary omega-3 polyunsaturated fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils. J Clin Invest 91:651-60
Avraham, S; Avraham, H; Austen, K F et al. (1992) Negative and positive cis-acting elements in the promoter of the mouse gene that encodes the serine/glycine-rich peptide core of secretory granule proteoglycans. J Biol Chem 267:610-7
Sperling, R I; Benincaso, A I; Anderson, R J et al. (1992) Acute and chronic suppression of leukotriene B4 synthesis ex vivo in neutrophils from patients with rheumatoid arthritis beginning treatment with methotrexate. Arthritis Rheum 35:376-84
Gladman, D D; Goldsmith, C H; Urowitz, M B et al. (1992) Crosscultural validation and reliability of 3 disease activity indices in systemic lupus erythematosus. J Rheumatol 19:608-11
Kay, J; Benson, C B; Lester, S et al. (1992) Utility of high-resolution ultrasound for the diagnosis of dialysis-related amyloidosis. Arthritis Rheum 35:926-32
Serafin, W E; Sullivan, T P; Conder, G A et al. (1991) Cloning of the cDNA and gene for mouse mast cell protease 4. Demonstration of its late transcription in mast cell subclasses and analysis of its homology to subclass-specific neutral proteases of the mouse and rat. J Biol Chem 266:1934-41
Kumar, A; Kumar, P; Schur, P H (1991) DR3 and nonDR3 associated complement component C4A deficiency in systemic lupus erythematosus. Clin Immunol Immunopathol 60:55-64

Showing the most recent 10 out of 27 publications